How do you pay?

How to pay the least

Ask for the cash price

Subvenite

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you.

  1. Ask your pharmacy for Subvenite’s cash price, and one or two other pharmacies too.
  2. Subvenite’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameSubvenite
Authorized genericlamotrigine
Regular genericlamotrigine
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Other forms onlyAsk your doctor
Same as Subvenite?
The original
–
–

Brand nameThe maker’s card

SUBVENITE Savings Program

Savings card from OWP Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Print the card (PDF) 

See the offer on subvenite.com

In the maker’s words

“Eligible patients present this Savings Card (either printed OR on a mobile device) to pay as little as $0.”

From the maker’s offer on subvenite.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Subvenite itself, from the same company, sold without the brand name, and usually for less. For now Subvenite is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

SUBVENITE is indicated for:

Epilepsy—adjunctive therapy in patients aged 2 years and older:

  • partial-onset seizures
  • primary generalized tonic-clonic (PGTC) seizures
  • generalized seizures of Lennox-Gastaut syndrome.

Epilepsy—monotherapy in patients aged 16 years and older: Conversion to monotherapy in patients with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug.

Bipolar disorder: Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy.

Limitations of Use: Treatment of acute manic or mixed episodes is not recommended. Effectiveness of SUBVENITE in the acute treatment of mood episodes has not been established.

Source: the FDA label for Subvenite (OWP Pharmaceuticals, Inc.), June 4, 2026. Full label on DailyMed 

Good to know